Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
Academic Article
Publication Date:
2004
CRIS type:
1.1 Articolo in rivista
List of contributors:
Alessandri, C; Bombardieri, M; Papa, N; Cinquini, M; Magrini, L; Tincani, Angela; Valesini, G.
Published in: